Spiration, Inc.
Medical Devices & Tech  Advamed Member
6675 185th Avenue NE
Redmond, WA 98052 USA
phone: 425-497-1700
fax: 425-497-1912
Symbol private
Exchange
Founded 0
Employees
www.spirationinc.com
Research Sector Medical Devices & Tech
Summary Description
Thoracic and intra-bronchial medical devices for the treatment of lung disease.
Management
Richard Shea, Pres. & CEO; Steven C. Springmeyer, VP & Medical Director; Xavier Gonzalez, M.D., Vice President and Chief Scientific Officer; Gregory Sessler, Executive Vice President and Chief Financial Officer; Ken Beres, Vice President, Clinical Development
Ownership
Financials


* numbers in thousands

 
Keywords
lung disease, emphysema, lung cancer, bronchitis, copd, pulmonary, disease, advamed

Comment | Printable Version | Apr. 12, 2007
If you work for Spiration, Inc. and want to update this profile, click here

Description
Spiration, Inc. designs and manufactures innovative thoracic and intra-bronchial medical devices for the treatment of lung disease, including chronic obstructive pulmonary disease (COPD), specifically emphysema.
Products / Services
The VALR Surgical System is designed for use in thoracic surgical procedures to seal and resect lung tissue. The device is currently being studied clinically in lung volume reduction surgery in patients with COPD and emphysema, and is designed to reduce post-operative complications associated with prolonged air leaks. The Intra-Bronchial Valve is a minimally invasive device that reduces lung volume, improving lung function in patients with emphysema. The minimally invasive nature of the valve represents a treatment option for emphysema patients not eligible for surgery due to age or other co-morbidities. The Intra-Bronchial Valve is an umbrella-shaped valve placed in the bronchial tree using standard bronchoscopic techniques to seal airways and reduce the volume of selected portions of the lung.
Market / Customers
Chronic obstructive pulmonary disease is the fourth leading cause of death in the U.S., claiming the lives of more than 119,000 Americans annually. By 2010, COPD is predicted to be the third leading cause of death. Lung cancer is the leading cancer killer in both men and women, accounting for approximately 13 percent of all cancer diagnoses and 28 percent of cancer deaths in the U.S. In 2003, the American Cancer Society estimates more than 171,000 people will be diagnosed with lung cancer and an estimated 157,200 people will die from the disease in the United States.


2008-11-21-470